(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LGALS3 mRNA] CTD PMID:31150632 1,1-dichloroethene increases expression ISO RGD:736305 6480464 vinylidene chloride results in increased expression of LGALS3 mRNA CTD PMID:26682919 1,4-dichlorobenzene increases expression ISO RGD:736305 6480464 4-dichlorobenzene results in increased expression of LGALS3 mRNA CTD PMID:26975756 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of LGALS3 mRNA CTD PMID:17522070 more ... 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of LGALS3 mRNA CTD PMID:17557909 17beta-estradiol affects expression ISO RGD:736305 6480464 Estradiol affects the expression of LGALS3 mRNA CTD PMID:15598610 17beta-estradiol multiple interactions ISO RGD:736304 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of LGALS3 mRNA, [Estradiol co-treated with Progesterone] results in decreased expression of LGALS3 mRNA CTD PMID:20660070 , PMID:20823114 17beta-estradiol increases expression ISO RGD:736305 6480464 Estradiol results in increased expression of LGALS3 mRNA CTD PMID:15289156 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736305 6480464 Tetrachlorodibenzodioxin results in decreased expression of LGALS3 mRNA CTD PMID:20159946 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:736305 6480464 Tetrachlorodibenzodioxin results in increased expression of LGALS3 mRNA CTD PMID:17035482 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:736304 6480464 Tetrachlorodibenzodioxin results in increased expression of LGALS3 mRNA CTD PMID:11489354 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:736305 6480464 Tetrachlorodibenzodioxin affects the expression of LGALS3 mRNA CTD PMID:21570461 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LGALS3 mRNA CTD PMID:20959002 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of LGALS3 mRNA CTD PMID:22298810 2-hydroxypropanoic acid increases expression ISO RGD:736304 6480464 Lactic Acid results in increased expression of LGALS3 mRNA CTD PMID:30851411 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of LGALS3 mRNA CTD PMID:15890375 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:20959002 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of LGALS3 mRNA CTD PMID:28522335 3-methylcholanthrene increases expression ISO RGD:736305 6480464 Methylcholanthrene results in increased expression of LGALS3 mRNA CTD PMID:20713471 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of LGALS3 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of LGALS3 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol decreases expression ISO RGD:736304 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of LGALS3 mRNA CTD PMID:25912373 4,4'-sulfonyldiphenol increases expression ISO RGD:736305 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of LGALS3 mRNA CTD PMID:30951980 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of LGALS3 mRNA CTD PMID:15890375 4-hydroxyphenyl retinamide decreases expression ISO RGD:736305 6480464 Fenretinide results in decreased expression of LGALS3 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine increases expression ISO RGD:736304 6480464 Decitabine results in increased expression of LGALS3 mRNA CTD PMID:19194470 5-fluorouracil affects response to substance ISO RGD:736304 6480464 LGALS3 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 5-fluorouracil decreases response to substance ISO RGD:736304 6480464 LGALS3 protein mutant form results in decreased susceptibility to Fluorouracil CTD PMID:21750908 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of LGALS3 mRNA CTD PMID:24780913 7,12-dimethyltetraphene affects expression ISO RGD:736305 6480464 9 more ... CTD PMID:21785161 acetamide increases expression EXP 6480464 acetamide results in increased expression of LGALS3 mRNA CTD PMID:31881176 actinomycin D multiple interactions ISO RGD:736304 6480464 Dactinomycin inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of LGALS3 protein] CTD PMID:21821001 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of LGALS3 mRNA CTD PMID:15890375 aflatoxin B1 increases expression ISO RGD:736304 6480464 Aflatoxin B1 results in increased expression of LGALS3 mRNA CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:736305 6480464 Aflatoxin B1 results in decreased expression of LGALS3 mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO RGD:736304 6480464 Tretinoin results in decreased expression of LGALS3 mRNA CTD PMID:12875902 all-trans-retinoic acid increases expression ISO RGD:736304 6480464 Tretinoin results in increased expression of LGALS3 mRNA CTD PMID:23724009 all-trans-retinoic acid decreases expression ISO RGD:736305 6480464 Tretinoin results in decreased expression of LGALS3 mRNA CTD PMID:16604517 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of LGALS3 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of LGALS3 mRNA CTD PMID:30779732 arsenous acid increases expression ISO RGD:736304 6480464 Arsenic Trioxide results in increased expression of LGALS3 mRNA CTD PMID:20458559 benzo[a]pyrene increases expression ISO RGD:736305 6480464 Benzo(a)pyrene results in increased expression of LGALS3 mRNA CTD PMID:22228805 , PMID:23735875 benzo[a]pyrene increases methylation ISO RGD:736304 6480464 Benzo(a)pyrene results in increased methylation of LGALS3 5' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:736304 6480464 Benzo(a)pyrene affects the methylation of LGALS3 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:736304 6480464 Benzo(a)pyrene results in increased expression of LGALS3 mRNA, Benzo(a)pyrene results in increased expression of LGALS3 protein CTD PMID:16269432 more ... benzo[b]fluoranthene increases expression ISO RGD:736304 6480464 benzo(b)fluoranthene results in increased expression of LGALS3 mRNA CTD PMID:16269432 beta-naphthoflavone increases expression ISO RGD:736304 6480464 beta-Naphthoflavone results in increased expression of LGALS3 mRNA CTD PMID:19737606 bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of LGALS3 mRNA CTD PMID:16648578 bezafibrate increases expression ISO RGD:736305 6480464 Bezafibrate results in increased expression of LGALS3 mRNA CTD PMID:17118139 bis(2-ethylhexyl) phthalate increases expression ISO RGD:736304 6480464 Diethylhexyl Phthalate results in increased expression of LGALS3 mRNA CTD PMID:31163220 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LGALS3 mRNA CTD PMID:25181051 bisphenol A affects expression ISO RGD:736304 6480464 bisphenol A affects the expression of LGALS3 mRNA CTD PMID:30903817 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of LGALS3 gene CTD PMID:28505145 bisphenol F increases expression ISO RGD:736305 6480464 bisphenol F results in increased expression of LGALS3 mRNA CTD PMID:30951980 bleomycin A2 increases expression ISO RGD:736305 6480464 Bleomycin results in increased expression of LGALS3 protein CTD PMID:26526764 bleomycin A2 multiple interactions ISO RGD:736305 6480464 NOS2 protein affects the reaction [Bleomycin results in increased expression of LGALS3 protein] CTD PMID:26526764 bucladesine multiple interactions ISO RGD:736304 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of LGALS3 mRNA CTD PMID:20823114 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of LGALS3 mRNA CTD PMID:24136188 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of LGALS3 mRNA CTD PMID:22110744 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of LGALS3 mRNA CTD PMID:25993096 calcitriol decreases expression ISO RGD:736304 6480464 Calcitriol results in decreased expression of LGALS3 mRNA CTD PMID:12875902 calyculin a increases expression ISO RGD:736305 6480464 calyculin A results in increased expression of LGALS3 mRNA CTD PMID:25270620 carbon nanotube affects expression ISO RGD:736305 6480464 Nanotubes, Carbon affects the expression of LGALS3 mRNA CTD PMID:23845593 carbon nanotube increases expression ISO RGD:736305 6480464 Nanotubes, Carbon analog results in increased expression of LGALS3 mRNA, Nanotubes, Carbon results in increased expression of LGALS3 mRNA CTD PMID:25554681 , PMID:27106021 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of LGALS3 mRNA CTD PMID:18500788 chloroform increases expression EXP 6480464 Chloroform results in increased expression of LGALS3 mRNA CTD PMID:17522070 choline multiple interactions ISO RGD:736305 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LGALS3 mRNA CTD PMID:20938992 ciglitazone multiple interactions ISO RGD:736304 6480464 [ciglitazone binds to PPARG protein] which results in increased expression of LGALS3 mRNA CTD PMID:16197558 cisplatin multiple interactions ISO RGD:736304 6480464 4-benzyl-2-methyl-1 more ... CTD PMID:21368866 , PMID:21821001 cisplatin decreases response to substance ISO RGD:736304 6480464 GAL3 protein results in decreased susceptibility to Cisplatin more ... CTD PMID:21368866 more ... cisplatin increases expression ISO RGD:736304 6480464 Cisplatin results in increased expression of LGALS3 mRNA, Cisplatin results in increased expression of LGALS3 protein CTD PMID:21821001 , PMID:27392435 clofibrate increases expression ISO RGD:736305 6480464 Clofibrate results in increased expression of LGALS3 mRNA CTD PMID:17585979 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of LGALS3 mRNA CTD PMID:24386269 copper(II) sulfate increases expression ISO RGD:736304 6480464 Copper Sulfate results in increased expression of LGALS3 mRNA CTD PMID:19549813 cycloheximide multiple interactions ISO RGD:736304 6480464 Cycloheximide inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of LGALS3 protein] CTD PMID:21821001 cyclosporin A increases expression ISO RGD:736304 6480464 Cyclosporine results in increased expression of LGALS3 mRNA CTD PMID:25562108 , PMID:27989131 dexamethasone multiple interactions ISO RGD:736304 6480464 [GCS-100 co-treated with Dexamethasone] results in decreased expression of LGALS3 protein CTD PMID:16166312 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of LGALS3 mRNA CTD PMID:17522070 diarsenic trioxide increases expression ISO RGD:736304 6480464 Arsenic Trioxide results in increased expression of LGALS3 mRNA CTD PMID:20458559 dibenz[a,h]anthracene increases expression ISO RGD:736304 6480464 1 more ... CTD PMID:16269432 dibenzo[a,l]pyrene increases expression ISO RGD:736304 6480464 dibenzo(a, l)pyrene results in increased expression of LGALS3 protein CTD PMID:18495319 diclofenac increases expression ISO RGD:736305 6480464 Diclofenac results in increased expression of LGALS3 mRNA CTD PMID:26934552 dicrotophos decreases expression ISO RGD:736304 6480464 dicrotophos results in decreased expression of LGALS3 mRNA CTD PMID:28302478 diethylstilbestrol increases expression ISO RGD:736305 6480464 Diethylstilbestrol results in increased expression of LGALS3 mRNA CTD PMID:15289156 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of LGALS3 mRNA CTD PMID:15890375 dimethylarsinic acid increases expression EXP 6480464 Cacodylic Acid results in increased expression of LGALS3 mRNA CTD PMID:16122865 dioxygen increases expression ISO RGD:736305 6480464 Oxygen deficiency results in increased expression of LGALS3 mRNA CTD PMID:17193925 dioxygen multiple interactions ISO RGD:736305 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LGALS3 mRNA, [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of LGALS3 mRNA CTD PMID:19640911 , PMID:30529165 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of LGALS3 protein, Oxygen results in increased expression of LGALS3 mRNA CTD PMID:22911455 , PMID:32003113 diuron increases expression EXP 6480464 Diuron results in increased expression of LGALS3 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:736304 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases response to substance ISO RGD:736304 6480464 LGALS3 mRNA results in decreased susceptibility to Doxorubicin CTD PMID:16322897 doxorubicin increases expression ISO RGD:736304 6480464 Doxorubicin results in increased expression of LGALS3 mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of LGALS3 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:736304 6480464 entinostat results in increased expression of LGALS3 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:736304 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386 erythromycin estolate increases expression EXP 6480464 Erythromycin Estolate results in increased expression of LGALS3 mRNA CTD PMID:17522070 etoposide affects response to substance ISO RGD:736304 6480464 LGALS3 protein affects the susceptibility to Etoposide CTD PMID:16217747 fenamidone increases expression ISO RGD:736305 6480464 fenamidone results in increased expression of LGALS3 mRNA CTD PMID:27029645 flurbiprofen increases expression ISO RGD:736305 6480464 Flurbiprofen results in increased expression of LGALS3 mRNA CTD PMID:16949054 folic acid increases expression EXP 6480464 Folic Acid results in increased expression of LGALS3 mRNA CTD PMID:10980121 folic acid multiple interactions ISO RGD:736305 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LGALS3 mRNA CTD PMID:20938992 genistein increases expression ISO RGD:736305 6480464 Genistein results in increased expression of LGALS3 mRNA CTD PMID:15289156 glafenine increases expression EXP 6480464 Glafenine results in increased expression of LGALS3 mRNA CTD PMID:24136188 isoprenaline increases expression ISO RGD:736305 6480464 Isoproterenol results in increased expression of LGALS3 mRNA CTD PMID:20003209 L-ascorbic acid increases expression EXP 6480464 Ascorbic Acid results in increased expression of LGALS3 mRNA CTD PMID:15372504 L-methionine multiple interactions ISO RGD:736305 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LGALS3 mRNA CTD PMID:20938992 lactose affects binding ISO RGD:736304 6480464 Lactose binds to LGALS3 protein CTD PMID:17385862 leflunomide increases expression ISO RGD:736304 6480464 leflunomide results in increased expression of LGALS3 mRNA CTD PMID:28988120 , PMID:29427785 LY294002 multiple interactions ISO RGD:736304 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of and affects the localization of LGALS3 protein more ... CTD PMID:21821001 LY294002 decreases response to substance ISO RGD:736304 6480464 LGALS3 results in decreased susceptibility to 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one CTD PMID:21821001 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of LGALS3 mRNA CTD PMID:28801915 medroxyprogesterone acetate multiple interactions ISO RGD:736304 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of LGALS3 mRNA CTD PMID:20823114 mercury dibromide increases expression ISO RGD:736304 6480464 mercuric bromide results in increased expression of LGALS3 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:736304 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of LGALS3 mRNA CTD PMID:15890375 methimazole increases expression ISO RGD:736304 6480464 Methimazole results in increased expression of LGALS3 mRNA CTD PMID:20144635 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of LGALS3 gene CTD PMID:23303685 methylmercury chloride decreases expression ISO RGD:736304 6480464 methylmercuric chloride results in decreased expression of LGALS3 mRNA CTD PMID:23179753 methylmercury chloride increases expression ISO RGD:736304 6480464 methylmercuric chloride results in increased expression of LGALS3 mRNA CTD PMID:28001369 microcystin-LR increases expression ISO RGD:736305 6480464 cyanoginosin LR results in increased expression of LGALS3 mRNA CTD PMID:17654400 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of LGALS3 mRNA CTD PMID:25972201 mitomycin C affects response to substance ISO RGD:736304 6480464 LGALS3 protein affects the susceptibility to Mitomycin CTD PMID:16217747 monocrotaline multiple interactions EXP 6480464 [Monocrotaline co-treated with LGALS3 protein] inhibits the reaction [[Monocrotaline co-treated with TGFB1] results in decreased expression of MMP9 protein] more ... CTD PMID:27870162 N-acetylsphingosine increases expression ISO RGD:736304 6480464 N-acetylsphingosine results in increased expression of LGALS3 protein CTD PMID:21821001 N-acetylsphingosine decreases response to substance ISO RGD:736304 6480464 LGALS3 results in decreased susceptibility to N-acetylsphingosine CTD PMID:21821001 N-acetylsphingosine multiple interactions ISO RGD:736304 6480464 4-benzyl-2-methyl-1 more ... CTD PMID:21821001 N-ethyl-N-nitrosourea increases expression EXP 6480464 Ethylnitrosourea results in increased expression of LGALS3 mRNA CTD PMID:15954086 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO RGD:736305 6480464 [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LGALS3 mRNA CTD PMID:19840844 N-methyl-N-nitrosourea decreases expression ISO RGD:736305 6480464 Methylnitrosourea results in decreased expression of LGALS3 mRNA CTD PMID:25270620 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of LGALS3 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LGALS3 mRNA CTD PMID:28943392 N-nitrosodiethylamine multiple interactions ISO RGD:736305 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LGALS3 mRNA CTD PMID:24535843 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of LGALS3 mRNA CTD PMID:15890375 , PMID:25380136 N-nitrosodimethylamine increases expression ISO RGD:736304 6480464 Dimethylnitrosamine results in increased expression of LGALS3 mRNA CTD PMID:17547211 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of LGALS3 mRNA CTD PMID:19716841 naloxone increases expression EXP 6480464 Naloxone results in increased expression of LGALS3 mRNA CTD PMID:17522070 nickel atom increases expression ISO RGD:736305 6480464 Nickel results in increased expression of LGALS3 mRNA CTD PMID:12540486 nickel subsulfide increases expression EXP 6480464 nickel subsulfide results in increased expression of LGALS3 mRNA CTD PMID:21086188 nickel sulfate affects expression ISO RGD:736305 6480464 nickel sulfate affects the expression of LGALS3 mRNA CTD PMID:12718980 nickel sulfate decreases expression ISO RGD:736304 6480464 nickel sulfate results in decreased expression of LGALS3 mRNA CTD PMID:18651567 Nonylphenol increases expression ISO RGD:736304 6480464 nonylphenol results in increased expression of LGALS3 protein CTD PMID:16054331 oxycodone decreases expression EXP 6480464 Oxycodone results in decreased expression of LGALS3 mRNA CTD PMID:23439660 ozone increases expression EXP 6480464 Ozone results in increased expression of LGALS3 protein CTD PMID:22727909 panobinostat increases expression ISO RGD:736304 6480464 panobinostat results in increased expression of LGALS3 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:736304 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:736305 6480464 Acetaminophen affects the expression of LGALS3 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:736304 6480464 Acetaminophen results in decreased expression of LGALS3 mRNA CTD PMID:26690555 paracetamol affects response to substance ISO RGD:736305 6480464 LGALS3 protein affects the susceptibility to Acetaminophen CTD PMID:22461450 paracetamol multiple interactions ISO RGD:736305 6480464 LGALS3 protein affects the reaction [Acetaminophen results in increased expression of CCL20 mRNA] more ... CTD PMID:22461450 paracetamol increases expression ISO RGD:736305 6480464 Acetaminophen results in increased expression of LGALS3 mRNA, Acetaminophen results in increased expression of LGALS3 protein CTD PMID:22461450 paraquat increases expression EXP 6480464 Paraquat results in increased expression of LGALS3 protein CTD PMID:24521700 perfluorooctanoic acid increases expression ISO RGD:736304 6480464 perfluorooctanoic acid results in increased expression of LGALS3 protein CTD PMID:26879310 phenacetin increases expression EXP 6480464 Phenacetin results in increased expression of LGALS3 mRNA CTD PMID:17082564 , PMID:17698508 phenobarbital multiple interactions ISO RGD:736305 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LGALS3 mRNA, NR1I3 protein affects the reaction [Phenobarbital results in increased expression of LGALS3 mRNA] CTD PMID:19482888 , PMID:24535843 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of LGALS3 mRNA CTD PMID:19162173 phenobarbital increases expression ISO RGD:736305 6480464 Phenobarbital results in increased expression of LGALS3 mRNA CTD PMID:19482888 phenylhydrazine increases expression EXP 6480464 phenylhydrazine results in increased expression of LGALS3 mRNA CTD PMID:17082564 , PMID:17698508 phenylmercury acetate increases expression ISO RGD:736304 6480464 Phenylmercuric Acetate results in increased expression of LGALS3 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:736304 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:736305 6480464 [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LGALS3 mRNA CTD PMID:19840844 phosgene affects expression ISO RGD:736305 6480464 Phosgene affects the expression of LGALS3 mRNA CTD PMID:16300373 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of LGALS3 mRNA CTD PMID:15890375 pirinixic acid multiple interactions ISO RGD:736304 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of LGALS3 mRNA CTD PMID:19710929 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of LGALS3 mRNA CTD PMID:15890375 pirinixic acid increases expression ISO RGD:736305 6480464 pirinixic acid results in increased expression of LGALS3 mRNA CTD PMID:17118139 potassium dichromate increases expression ISO RGD:736304 6480464 Potassium Dichromate results in increased expression of LGALS3 protein CTD PMID:23718831 progesterone affects metabolic processing ISO RGD:736305 6480464 LGALS3 protein affects the metabolism of Progesterone CTD PMID:17242467 progesterone multiple interactions ISO RGD:736304 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of LGALS3 mRNA CTD PMID:20660070 quercetin increases expression ISO RGD:736304 6480464 Quercetin results in increased expression of LGALS3 mRNA CTD PMID:21632981 quinolin-8-ol decreases expression ISO RGD:736304 6480464 Oxyquinoline results in decreased expression of LGALS3 mRNA CTD PMID:21632981 quinoline increases expression ISO RGD:736304 6480464 quinoline analog results in increased expression of LGALS3 protein CTD PMID:18645022 rac-lactic acid increases expression ISO RGD:736304 6480464 Lactic Acid results in increased expression of LGALS3 mRNA CTD PMID:30851411 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of LGALS3 mRNA CTD PMID:25905778 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of LGALS3 mRNA CTD PMID:25905778 rotenone increases expression EXP 6480464 Rotenone results in increased expression of LGALS3 mRNA CTD PMID:27900601 SB 431542 multiple interactions ISO RGD:736304 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:736305 6480464 Silicon Dioxide results in increased expression of LGALS3 mRNA CTD PMID:23221170 , PMID:29341224 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of LGALS3 mRNA CTD PMID:21602193 , PMID:22431001 sodium arsenite decreases expression ISO RGD:736305 6480464 sodium arsenite results in decreased expression of LGALS3 protein CTD PMID:29044176 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of LGALS3 mRNA CTD PMID:25993096 sodium fluoride decreases expression ISO RGD:736305 6480464 Sodium Fluoride results in decreased expression of LGALS3 protein CTD PMID:28918527 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of LGALS3 mRNA, vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of LGALS3 mRNA] CTD PMID:16684804 , PMID:25905778 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of LGALS3 mRNA CTD PMID:16684804 sulindac multiple interactions ISO RGD:736304 6480464 Sulindac inhibits the reaction [CDKN1A protein results in increased expression of LGALS3 mRNA] CTD PMID:15190207 sunitinib decreases expression ISO RGD:736304 6480464 Sunitinib results in decreased expression of LGALS3 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:736304 6480464 Tamoxifen affects the expression of LGALS3 mRNA CTD PMID:14699072 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of LGALS3 mRNA, Carbon Tetrachloride results in increased expression of LGALS3 protein CTD PMID:12629582 more ... tetrachloromethane decreases expression ISO RGD:736305 6480464 Carbon Tetrachloride results in decreased expression of LGALS3 protein CTD PMID:29044176 tetrachloromethane multiple interactions EXP 6480464 Carbon Tetrachloride promotes the reaction [PURB protein binds to LGALS3 promoter], schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LGALS3 mRNA] CTD PMID:16309856 , PMID:31150632 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of LGALS3 mRNA CTD PMID:12734012 tetrachloromethane multiple interactions ISO RGD:736305 6480464 LGALS3 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA] more ... CTD PMID:16549783 , PMID:23798564 tetrachloromethane affects expression ISO RGD:736305 6480464 Carbon Tetrachloride affects the expression of LGALS3 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:736305 6480464 Carbon Tetrachloride results in increased expression of LGALS3 mRNA, Carbon Tetrachloride results in increased expression of LGALS3 protein CTD PMID:16549783 more ... tetracycline increases expression EXP 6480464 Tetracycline results in increased expression of LGALS3 mRNA CTD PMID:17522070 theophylline increases expression EXP 6480464 Theophylline results in increased expression of LGALS3 mRNA CTD PMID:17522070 thioacetamide multiple interactions ISO RGD:736305 6480464 MGAT5 protein affects the reaction [Thioacetamide results in increased expression of LGALS3 mRNA] CTD PMID:23798564 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LGALS3 mRNA CTD PMID:28943392 thioacetamide increases expression ISO RGD:736305 6480464 Thioacetamide results in increased expression of LGALS3 mRNA CTD PMID:23798564 titanium dioxide increases expression ISO RGD:736305 6480464 titanium dioxide results in increased expression of LGALS3 mRNA CTD PMID:23409001 more ... tremolite asbestos increases expression ISO RGD:736305 6480464 tremolite results in increased expression of LGALS3 mRNA CTD PMID:29279043 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of LGALS3 gene CTD PMID:27618143 trichostatin A increases expression ISO RGD:736304 6480464 trichostatin A results in increased expression of LGALS3 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:736304 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386 triclosan increases expression ISO RGD:736304 6480464 Triclosan results in increased expression of LGALS3 mRNA CTD PMID:30510588 tris(2-butoxyethyl) phosphate affects expression ISO RGD:736304 6480464 tris(2-butoxyethyl) phosphate affects the expression of LGALS3 mRNA CTD PMID:29024780 tungsten decreases expression ISO RGD:736305 6480464 Tungsten results in decreased expression of LGALS3 mRNA CTD PMID:30912803 tunicamycin increases expression ISO RGD:736305 6480464 Tunicamycin results in increased expression of LGALS3 mRNA CTD PMID:17127020 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of LGALS3 mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:736305 6480464 Valproic Acid affects the expression of LGALS3 mRNA CTD PMID:17963808 valproic acid multiple interactions ISO RGD:736304 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:736304 6480464 Valproic Acid results in increased expression of LGALS3 mRNA CTD PMID:19101580 more ... valproic acid affects expression ISO RGD:736304 6480464 Valproic Acid affects the expression of LGALS3 mRNA CTD PMID:25979313 vanadyl sulfate multiple interactions EXP 6480464 vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of LGALS3 mRNA] CTD PMID:16684804 vancomycin decreases expression ISO RGD:736305 6480464 Vancomycin results in decreased expression of LGALS3 mRNA CTD PMID:18930951 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of LGALS3 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of LGALS3 mRNA CTD PMID:23034163 vorinostat increases expression ISO RGD:736304 6480464 vorinostat results in increased expression of LGALS3 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:736304 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA CTD PMID:27188386
Biological Process antimicrobial humoral immune response mediated by antimicrobial peptide ISO RGD:736304 1624291 (PMID:16982911) RGD PMID:16982911 eosinophil chemotaxis ISO RGD:736304 1624291 (PMID:10925302) RGD PMID:10925302 eosinophil chemotaxis IBA PANTHER:PTN002602519 , UniProtKB:P17931 13792537 PMID:21873635 GO_Central eosinophil chemotaxis IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 epithelial cell differentiation ISO RGD:736304 1624291 (PMID:21492153) RGD PMID:21492153 epithelial cell differentiation IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 extracellular matrix organization ISO RGD:736305 1624291 MGI:MGI:97011 (MGI:MGI:3589495 , PMID:15800063) RGD MGI:MGI:3589495 , PMID:15800063 innate immune response IEA UniProtKB-KW:KW-0399 1600115 GO_REF:0000043 UniProt GO_REF:0000043 killing of cells of other organism ISO RGD:736304 1624291 (PMID:16982911) RGD PMID:16982911 macrophage chemotaxis ISO RGD:736304 1624291 (PMID:10925302) RGD PMID:10925302 macrophage chemotaxis IBA PANTHER:PTN002602519 , UniProtKB:P17931 13792537 PMID:21873635 GO_Central macrophage chemotaxis IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 maintenance of protein location NOT ISO RGD:736305 1624291 (MGI:MGI:5014432, PMID:21670307) RGD MGI:MGI:5014432 , PMID:21670307 monocyte chemotaxis ISO RGD:736304 1624291 (PMID:10925302) RGD PMID:10925302 monocyte chemotaxis IBA PANTHER:PTN002602519 , UniProtKB:P17931 13792537 PMID:21873635 GO_Central monocyte chemotaxis IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 mononuclear cell migration ISO RGD:736304 1624291 (PMID:10925302) RGD PMID:10925302 mRNA processing IEA UniProtKB-KW:KW-0507 1600115 GO_REF:0000043 UniProt GO_REF:0000043 negative regulation of apoptotic process IDA 9685204 RGD negative regulation of cell proliferation in bone marrow IDA 9685208 RGD negative regulation of endocytosis ISO RGD:736305 1624291 (MGI:MGI:4355752, PMID:19706535) RGD MGI:MGI:4355752 , PMID:19706535 negative regulation of endocytosis IBA MGI:MGI:96778 more ... 13792537 PMID:21873635 GO_Central negative regulation of endocytosis IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of endocytosis ISO RGD:736304 1624291 (PMID:19706535) RGD PMID:19706535 negative regulation of extrinsic apoptotic signaling pathway ISO RGD:736304 1624291 (PMID:22761016) RGD PMID:22761016 negative regulation of extrinsic apoptotic signaling pathway IBA PANTHER:PTN002602519 , UniProtKB:P17931 13792537 PMID:21873635 GO_Central negative regulation of extrinsic apoptotic signaling pathway IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of immunological synapse formation ISO RGD:736305 1624291 (MGI:MGI:4355752, PMID:19706535) RGD MGI:MGI:4355752 , PMID:19706535 negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell ISO RGD:736305 1624291 (MGI:MGI:4355752, PMID:19706535) RGD MGI:MGI:4355752 , PMID:19706535 negative regulation of T cell receptor signaling pathway ISO RGD:736305 1624291 (MGI:MGI:4355752, PMID:19706535) RGD MGI:MGI:4355752 , PMID:19706535 neutrophil chemotaxis ISO RGD:736304 1624291 (PMID:10925302) RGD PMID:10925302 neutrophil chemotaxis IBA PANTHER:PTN002602519 , UniProtKB:P17931 13792537 PMID:21873635 GO_Central neutrophil chemotaxis IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive chemotaxis ISO RGD:736304 1624291 (PMID:10925302) RGD PMID:10925302 positive chemotaxis IBA PANTHER:PTN002602519 , UniProtKB:P17931 13792537 PMID:21873635 GO_Central positive chemotaxis IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of angiogenesis IMP 9685216 RGD positive regulation of calcium ion import ISO RGD:736304 1624291 (PMID:10925302) RGD PMID:10925302 positive regulation of calcium ion import IBA PANTHER:PTN002602519 , UniProtKB:P17931 13792537 PMID:21873635 GO_Central positive regulation of calcium ion import IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of cell population proliferation IMP 9685216 RGD positive regulation of dendritic cell differentiation NOT ISO RGD:736304 1624291 (PMID:16116184) RGD PMID:16116184 positive regulation of mononuclear cell migration ISO RGD:736304 1624291 (PMID:10925302) RGD PMID:10925302 positive regulation of mononuclear cell migration IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of protein localization to plasma membrane IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of protein localization to plasma membrane ISO RGD:736304 1624291 (PMID:24846175) RGD PMID:24846175 positive regulation of protein-containing complex assembly ISO RGD:736304 1624291 (PMID:24846175) RGD PMID:24846175 positive regulation of protein-containing complex assembly IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of serotonin secretion IDA 9685207 RGD regulation of extrinsic apoptotic signaling pathway via death domain receptors ISO RGD:736304 1624291 (PMID:8692888) RGD PMID:8692888 regulation of extrinsic apoptotic signaling pathway via death domain receptors IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of T cell apoptotic process ISO RGD:736304 1624291 (PMID:8692888) RGD PMID:8692888 regulation of T cell apoptotic process IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of T cell proliferation ISO RGD:736304 1624291 (PMID:8692888) RGD PMID:8692888 regulation of T cell proliferation IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 RNA splicing IEA UniProtKB-KW:KW-0508 1600115 GO_REF:0000043 UniProt GO_REF:0000043 skeletal system development ISO RGD:736305 1624291 MGI:MGI:97011 (MGI:MGI:3589495 , PMID:15800063) RGD MGI:MGI:3589495 , PMID:15800063 Cellular Component cell surface IDA 9685208 RGD cell surface IDA 13792533 PMID:21401967 ARUK-UCL cell surface ISO RGD:736305 1624291 (MGI:MGI:5619731, PMID:23576987) RGD MGI:MGI:5619731 , PMID:23576987 cytoplasm IDA 9685215 RGD cytoplasm IEA UniProtKB-SubCell:SL-0086 1600115 GO_REF:0000044 UniProt GO_REF:0000044 cytoplasm IBA MGI:MGI:1929094 more ... 13792537 PMID:21873635 GO_Central cytoplasm ISO RGD:736305 1624291 (MGI:MGI:1355019 more ... RGD MGI:MGI:1355019 more ... cytoplasm ISO RGD:736304 1624291 (PMID:14961764), (PMID:22761016), (PMID:9447709) RGD PMID:14961764 more ... external side of plasma membrane ISO RGD:736305 1624291 (MGI:MGI:5475059, PMID:23460747) RGD MGI:MGI:5475059 , PMID:23460747 extracellular matrix ISO RGD:736305 1624291 (MGI:MGI:3589495, PMID:15800063) RGD MGI:MGI:3589495 , PMID:15800063 extracellular space IDA 9685208 RGD extracellular space IBA PANTHER:PTN002602519 , RGD:69356 13792537 PMID:21873635 GO_Central glial cell projection ISO RGD:736305 1624291 (MGI:MGI:4831065, PMID:20826656) RGD MGI:MGI:4831065 , PMID:20826656 immunological synapse ISO RGD:736305 1624291 (MGI:MGI:4355752, PMID:19706535) RGD MGI:MGI:4355752 , PMID:19706535 immunological synapse IBA MGI:MGI:96778 more ... 13792537 PMID:21873635 GO_Central immunological synapse IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 immunological synapse ISO RGD:736304 1624291 (PMID:19706535) RGD PMID:19706535 mitochondrial inner membrane ISO RGD:736304 1624291 (PMID:19016746) RGD PMID:19016746 mitochondrial inner membrane IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 nucleus IDA 9685215 RGD nucleus IBA MGI:MGI:96778 more ... 13792537 PMID:21873635 GO_Central nucleus ISO RGD:736304 1624291 (PMID:14961764), (PMID:22761016), (PMID:7682704) RGD PMID:14961764 more ... nucleus ISO RGD:736305 1624291 (MGI:MGI:1355019, PMID:10745073) RGD MGI:MGI:1355019 , PMID:10745073 other organism cell colocalizes_with ISO RGD:736304 1624291 (PMID:16982911) RGD PMID:16982911 other organism cell ISO RGD:736304 1624291 (PMID:16982911) RGD PMID:16982911 plasma membrane TAS 1600115 Reactome:R-NUL-879372 Reactome Reactome:R-NUL-879372 spliceosomal complex IEA UniProtKB-KW:KW-0747 1600115 GO_REF:0000043 UniProt GO_REF:0000043 Molecular Function advanced glycation end-product receptor activity IDA 9685219 RGD carbohydrate binding IEA UniRule:UR000102079 1600115 GO_REF:0000104 UniProt GO_REF:0000104 chemoattractant activity ISO RGD:736304 1624291 (PMID:10925302) RGD PMID:10925302 chemoattractant activity IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 disaccharide binding IDA 9685211 RGD Fc-gamma receptor I complex binding IDA 9685207 RGD IgE binding IDA 9685211 RGD IgE binding IEA UniProtKB-KW:KW-0389 1600115 GO_REF:0000043 UniProt GO_REF:0000043 IgE binding IBA PANTHER:PTN002602519 more ... 13792537 PMID:21873635 GO_Central IgE binding IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 IgE binding ISO RGD:736304 1624291 (PMID:2261464) RGD PMID:2261464 laminin binding ISO RGD:736304 1624291 (PMID:2402511) RGD PMID:2402511 laminin binding IBA PANTHER:PTN002602519 , UniProtKB:P17931 13792537 PMID:21873635 GO_Central laminin binding IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 monosaccharide binding IDA 9685211 RGD oligosaccharide binding ISO RGD:736304 1624291 (PMID:16982911) RGD PMID:16982911 protein binding ISO RGD:736304 1624291 UniProtKB:O14931 more ... RGD PMID:19016746 more ... protein binding ISO RGD:736305 1624291 PR:Q9JLB4 more ... RGD MGI:MGI:1355019 more ... protein phosphatase binding IEA UniProtKB:P17931 , ensembl:ENSP000002543011600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein phosphatase binding ISO RGD:736304 1624291 UniProtKB:O14522 (PMID:24846175) RGD PMID:24846175
Gene-Chemical Interaction Annotations
